These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 36338939)

  • 21. Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation.
    Tian X; Zhao Q; Chen X; Peng Z; Tan X; Wang Q; Chen L; Yang Y
    Front Pharmacol; 2022; 13():817715. PubMed ID: 35264955
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening of potential drug from Azadirachta Indica (Neem) extracts for SARS-CoV-2: An insight from molecular docking and MD-simulation studies.
    Baildya N; Khan AA; Ghosh NN; Dutta T; Chattopadhyay AP
    J Mol Struct; 2021 Mar; 1227():129390. PubMed ID: 33041371
    [No Abstract]   [Full Text] [Related]  

  • 23. Meticulous assessment of natural compounds from NPASS database for identifying analogue of GRL0617, the only known inhibitor for SARS-CoV2 papain-like protease (PLpro) using rigorous computational workflow.
    Parmar P; Rao P; Sharma A; Shukla A; Rawal RM; Saraf M; Patel BV; Goswami D
    Mol Divers; 2022 Feb; 26(1):389-407. PubMed ID: 34008129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying structural-functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation.
    Rao P; Patel R; Shukla A; Parmar P; Rawal RM; Saraf M; Goswami D
    Mol Divers; 2022 Feb; 26(1):309-329. PubMed ID: 33825097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of natural compounds (proanthocyanidin and rhapontin) as high-affinity inhibitors of SARS-CoV-2 Mpro and PLpro using computational strategies.
    AlAjmi MF; Azhar A; Hasan S; Alshabr AZ; Hussain A; Rehman MT
    Arch Med Sci; 2024; 20(2):567-581. PubMed ID: 38757037
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Huynh T; Cornell W; Luan B
    Front Chem; 2020; 8():624163. PubMed ID: 33614597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory efficacy of 2, 4-diacetylphloroglucinol against SARS-COV-2 proteins: in silico study.
    Kankariya RA; Chaudhari AB; Dandi ND
    Biologia (Bratisl); 2022; 77(3):815-828. PubMed ID: 35125499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2.
    Singh E; Jha RK; Khan RJ; Kumar A; Jain M; Muthukumaran J; Singh AK
    Comput Biol Chem; 2022 Aug; 99():107721. PubMed ID: 35835027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of small molecule PLpro inhibitor against COVID-19 using structure-based virtual screening, molecular dynamics simulation, and molecular mechanics/Generalized Born surface area (MM/GBSA) calculation.
    Pang J; Gao S; Sun Z; Yang G
    Struct Chem; 2021; 32(2):879-886. PubMed ID: 33106741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro.
    Swain SS; Singh SR; Sahoo A; Panda PK; Hussain T; Pati S
    Proteins; 2022 Sep; 90(9):1617-1633. PubMed ID: 35384056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs.
    Hosseini M; Chen W; Xiao D; Wang C
    Precis Clin Med; 2021 Mar; 4(1):1-16. PubMed ID: 33842834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
    Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
    J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Papain-Like Protease inhibitors of SARS CoV-2 through HTVS, Molecular docking, MMGBSA and Molecular dynamics approach.
    Jupudi S; Rajagopal K; Murugesan S; Kumar BK; Raman K; Byran G; Chennaiah J; Muthiah VP; Dasan P B; Sankaran S
    S Afr J Bot; 2022 Dec; 151():82-91. PubMed ID: 34876768
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
    Cetin A
    Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies.
    Ali Dahhas M; M Alkahtani H; Malik A; Almehizia AA; Bakheit AH; Akber Ansar S; AlAbdulkarim AS; S Alrasheed L; Alsenaidy MA
    Saudi Pharm J; 2023 Feb; 31(2):228-244. PubMed ID: 36540698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Rajendran M; Roy S; Ravichandran K; Mishra B; Gupta DK; Nagarajan S; Arul Selvaraj RC; Provaznik I
    J Biomol Struct Dyn; 2022 Apr; 40(7):3155-3169. PubMed ID: 33200680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some
    Amin SA; Ghosh K; Gayen S; Jha T
    J Biomol Struct Dyn; 2021 Aug; 39(13):4764-4773. PubMed ID: 32568618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Assessment of Docking Programs for Docking and Virtual Screening of Ribosomal Oxazolidinone Antibacterial Agents.
    Buckley ME; Ndukwe ARN; Nair PC; Rana S; Fairfull-Smith KE; Gandhi NS
    Antibiotics (Basel); 2023 Feb; 12(3):. PubMed ID: 36978331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.